1. Home
  2. EYPT vs SAFE Comparison

EYPT vs SAFE Comparison

Compare EYPT & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SAFE
  • Stock Information
  • Founded
  • EYPT 1987
  • SAFE 2016
  • Country
  • EYPT United States
  • SAFE United States
  • Employees
  • EYPT N/A
  • SAFE N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SAFE Real Estate Investment Trusts
  • Sector
  • EYPT Industrials
  • SAFE Real Estate
  • Exchange
  • EYPT Nasdaq
  • SAFE Nasdaq
  • Market Cap
  • EYPT 967.4M
  • SAFE 1.2B
  • IPO Year
  • EYPT 2005
  • SAFE 2017
  • Fundamental
  • Price
  • EYPT $11.76
  • SAFE $14.55
  • Analyst Decision
  • EYPT Strong Buy
  • SAFE Buy
  • Analyst Count
  • EYPT 5
  • SAFE 8
  • Target Price
  • EYPT $27.40
  • SAFE $19.88
  • AVG Volume (30 Days)
  • EYPT 1.4M
  • SAFE 309.2K
  • Earning Date
  • EYPT 11-05-2025
  • SAFE 11-05-2025
  • Dividend Yield
  • EYPT N/A
  • SAFE 4.86%
  • EPS Growth
  • EYPT N/A
  • SAFE N/A
  • EPS
  • EYPT N/A
  • SAFE 1.43
  • Revenue
  • EYPT $51,898,000.00
  • SAFE $393,596,000.00
  • Revenue This Year
  • EYPT N/A
  • SAFE $0.58
  • Revenue Next Year
  • EYPT N/A
  • SAFE $4.98
  • P/E Ratio
  • EYPT N/A
  • SAFE $10.18
  • Revenue Growth
  • EYPT 2.99
  • SAFE 2.22
  • 52 Week Low
  • EYPT $3.91
  • SAFE $13.43
  • 52 Week High
  • EYPT $14.91
  • SAFE $23.90
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 42.93
  • SAFE 35.76
  • Support Level
  • EYPT $11.15
  • SAFE $15.30
  • Resistance Level
  • EYPT $12.47
  • SAFE $15.84
  • Average True Range (ATR)
  • EYPT 0.68
  • SAFE 0.38
  • MACD
  • EYPT -0.08
  • SAFE -0.07
  • Stochastic Oscillator
  • EYPT 23.37
  • SAFE 4.04

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SAFE Safehold Inc. New

Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.

Share on Social Networks: